Enrichment analysis in LuminalB/HER2 + patients indicated the involvement of the PD-L1/PD-1 checkpoint and JAK-STAT signaling pathways, with the latter implicated in inducing PD-L1 expression in various cancers (Doi et al. 2017). The gene discussed is CD274; the disease is cancer.